Restricted accessResearch articleFirst published online 2017-04
miR-101 Enhances Cisplatin-Induced DNA Damage Through Decreasing Nicotinamide Adenine Dinucleotide Phosphate Levels by Directly Repressing Tp53-Induced Glycolysis and Apoptosis Regulator Expression in Prostate Cancer Cells
Tp53-induced glycolysis and apoptosis regulator (TIGAR) enhances the pentose phosphate pathway, thereby contributing directly to DNA repair due to generation of nicotinamide adenine dinucleotide phosphate (NADPH) and ribose-5-phosphate, two key precursors of DNA synthesis and repair. Targetscan database showed that miR-101 was predicted to potentially target TIGAR. Therefore, we speculated that miR-101 could enhance cisplatin-induced DNA damage by directly repressing TIGAR expression in prostate cancer cells. We found that upregulation of miR-101 inhibited viability, induced apoptosis, increased glycolysis rate and fructose-2,6-bisphosphate levels, decreased glucose-6-phosphate dehydrogenase expression and NADPH levels, and enhanced cisplatin-induced DNA damage in prostate cancer cells. We also demonstrated that TIGAR was a direct target of miR-101 by using luciferase activity assay. Furthermore, this study revealed that the roles of knockdown of TIGAR were similar to miR-101 upregulation in prostate cancer cells. Taken together, miR-101 inhibited viability, induced apoptosis, reprogramed glucose metabolism, and enhanced cisplatin-induced DNA damage through decreasing NADPH levels by directly suppressing the expression of TIGAR in prostate cancer cells.
Get full access to this article
View all access options for this article.
References
1.
BensaadK., TsurutaA., SelakM.A., VidalM.N.C., NakanoK., BartronsR., et al. (2006). TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell, 126, 107–120.
2.
CaoH., MuY., LiX., WangY., ChenS., and LiuJ.P. (2016). A systematic review of randomized controlled trials on oral chinese herbal medicine for prostate cancer. PLoS One, 11, e0160253.
3.
CaoP., DengZ., WanM., HuangW., CramerS.D., XuJ., et al. (2010). MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β. Mol Cancer, 9, 108.
4.
ChakravarthiB.V., GoswamiM.T., PathiS.S., RobinsonA.D., CieślikM., ChandrashekarD.S., et al. (2016). MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer. Oncogene, 35, 6330–6340.
5.
ChandramouliA., OnyeaguchaB.C., Mercado-PimentelM.E., StankovaL., ShahinN.A., LaFleurB.J., et al. (2012). MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancers. Cancer Biol Ther, 13, 175–183.
6.
ChenW., ZhengR., BaadeP.D., ZhangS., ZengH., BrayF., et al. (2016). Cancer statistics in China, 2015. CA Cancer J Clin, 66, 115–132.
7.
DasariS., and TchounwouP.B. (2014). Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol, 740, 364–378.
8.
Ganapathy-KanniappanS., and GeschwindJ.-F.H. (2013). Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer, 12, 152.
9.
GaneshS., IyerA.K., WeilerJ., MorrisseyD.V., and AmijiM.M. (2013). Combination of siRNA-directed gene silencing with cisplatin reverses drug resistance in human non-small cell lung cancer. Mol Ther Nucl Acids, 2, e110.
10.
GuoP., LanJ., GeJ., NieQ., GuoL., QiuY., and MaoQ. (2014). MiR-26a enhances the radiosensitivity of glioblastoma multiforme cells through targeting of ataxia-telangiectasia mutated. Exp Cell Res, 320, 200–208.
11.
HaoY., GuX., ZhaoY., GreeneS., ShaW., SmootD.T., et al. (2011). Enforced expression of miR-101 Inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev Res, 4, 1073–1083.
12.
KumarB., IqbalM.A., SinghR.K., and BamezaiR.N. (2015). Resveratrol inhibits TIGAR to promote ROS induced apoptosis and autophagy. Biochimie, 118, 26–35.
13.
LiM., SunM., CaoL., GuJ.-h., GeJ., ChenJ., et al. (2014). A TIGAR-regulated metabolic pathway is critical for protection of brain ischemia. J Neurosci, 34, 7458–7471.
14.
LuiV.W.Y., LauC.P.Y., CheungC.S.F., HoK., NgM.H.L., ChengS.H., et al. (2010). An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl) cytosine (ECyd), elicits antitumor effect via TP53-induced glycolysis and apoptosis regulator (TIGAR) downregulation. Biochem Pharmacol, 79, 1772–1780.
15.
LuiV.W.Y., WongE.Y.L., HoK., NgP.K.S., LauC.P.Y., TsuiS.K.W., et al. (2011). Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death. Oncogene, 30, 1127–1134.
16.
PangY., YoungC.Y., and YuanH. (2010). MicroRNAs and prostate cancer. Acta Biochim Biophys Sin, 42, 363–369.
17.
PatraK.C., and HayN. (2014). The pentose phosphate pathway and cancer. Trends Biochem Sci, 39, 347–354.
18.
Peña-RicoM.A., Calvo-VidalM.N., Villalonga-PlanellsR., Martínez-SolerF., Giménez-BonaféP., Navarro-SabatéÀ., et al. (2011). TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells. Radiother Oncol, 101, 132–139.
19.
RigantiC., GazzanoE., PolimeniM., AldieriE., and GhigoD. (2012). The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate. Free Radic Biol Med, 53, 421–436.
20.
SchaftingenE., LedererB., BartronsR., and HersH.G. (1982). A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Eur J Biochem, 129, 191–195.
21.
TaiG., ZhangH., DuJ., ChenG., HuangJ., YuJ., et al. (2015). TIGAR overexpression diminishes radiosensitivity of parotid gland fibroblast cells and inhibits IR-induced cell autophagy. Int J Clin Exp Pathol, 8, 4823–4829.
22.
ValeC.L., BurdettS., RydzewskaL.H., AlbigesL., ClarkeN.W., FisherD., et al. (2016). Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data. Lancet Oncol, 17, 243–256.
23.
WangJ., YuanW., ChenZ., WuS., ChenJ., GeJ., et al. (2012). Overexpression of G6PD is associated with poor clinical outcome in gastric cancer. Tumor Biol, 33, 95–101.
24.
WankaC., SteinbachJ.P., and RiegerJ. (2012). Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis. J Biol Chem, 287, 33436–33446.
25.
YalcinA., ClemB.F., SimmonsA., LaneA., NelsonK., ClemA.L., et al. (2009). Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J Biol Chem, 284, 24223–24232.
26.
YanD., NgW.L., ZhangX., WangP., ZhangZ., MoY.-Y., et al. (2010). Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One, 5, e11397.
27.
YuH.-P., XieJ.-M., LiB., SunY.-H., GaoQ.-G., DingZ.-H., et al. (2015). TIGAR regulates DNA damage and repair through pentosephosphate pathway and Cdk5-ATM pathway. Sci Rep, 5, 9853.
28.
ZhangY.M., LiuJ.K., and WongT.Y. (2003). The DNA excision repair system of the highly radioresistant bacterium Deinococcus radiodurans is facilitated by the pentose phosphate pathway. Mol Microbiol, 48, 1317–1323.
